| (1) |
The Chief Executive Officer shall cause, in such manner as he or she considers most suitable— |
| (i) |
of the name and number under which such medicine, medical device or IVD is registered and the conditions, if any, subject to which such medicine, medical device or IVD is registered; |
| (ii) |
of the therapeutic efficacy and effect of such medicine; |
| (iii) |
of the purpose for which, the circumstances under which and the manner in which such medicine, medical device or IVD should be used; and |
| (iv) |
regarding any other matter concerning such medicine, medical device or IVD which, in the opinion of the Chief Executive Officer, may be of value to them; |
| (b) |
as soon as practicable after the registration of any medicine, medical device or IVD, other than a veterinary medicine, has been cancelled in terms of section 16, medical practitioners, dentists, pharmacists, the public in general and the holder of the certificate of registration issued in respect of such medicine, medical device or IVD to be informed of the cancellation of such registration. |
| (2) |
The provisions of subsection (1) shall apply mutatis mutandis in respect of any veterinary medicine, and for the purposes of such application the reference in that subsection to medical practitioners and dentists shall be deemed to be a reference to veterinarians. |
[Section 22 substituted by section 21 of Notice No. 434, GG 32148, dated 21 April 2009]
South African Institute for Drug Free Sport Act, 1997
